Expansion of T Cells and Cytogenetics of the CIK Cell Cultures
| Patient . | CD3+ Day 1 (%) . | CD3+CD56+ Day 1 (%) . | CD3+ Day 21 (%) . | CD3+CD56+ Day 21 (%) . | Exp CD3+ . | Exp CD3+CD56+ . | Cyto Ph+/ total . |
|---|---|---|---|---|---|---|---|
| G.H. | 44 | 1 | 97 | 41 | 28 | 525 | ND |
| K.D.* | 12 | 1 | 97 | 24 | 74 | 363 | 0/20 |
| M.R.† | 52 | 4 | 99 | 3 | 6 | 2.5 | 0/20 |
| M.B.U. | 63 | 2 | 99 | 11 | 26 | 109 | 0/20 |
| M.B.A. | 64 | 3 | 92 | 13 | 8.3 | 26.5 | 0/50 |
| S.T. | 4 | 0 | 93 | 12 | 32 | 85 | 1/25 |
| L.C. | 1 | 0 | 94 | 16 | 20.2 | 19.5 | 0/20 |
| A.Z. | 5 | 0 | 90 | 6 | 20 | 19.5 | 0/20 |
| S.S. | 45 | 2 | 96 | 21 | 17.8 | 111 | 0/20 |
| P.S. | 51 | 1 | 97 | 8 | 5.4 | 24.2 | 0/20 |
| R.D.† | 40 | 4 | 99 | 4 | 2.5 | 2 | 0/20 |
| R.G. | 2 | 1 | 99 | 45 | 67 | 117 | 0/20 |
| G.T. | 34 | 4 | 99 | 3 | 11 | 7 | 0/20 |
| Median | 44 | 1 | 97 | 12 | 20.2 | 26.5 | |
| Range | 1-64 | 0-4 | 90-99 | 3-45 | 2.5-74 | 2-525 |
| Patient . | CD3+ Day 1 (%) . | CD3+CD56+ Day 1 (%) . | CD3+ Day 21 (%) . | CD3+CD56+ Day 21 (%) . | Exp CD3+ . | Exp CD3+CD56+ . | Cyto Ph+/ total . |
|---|---|---|---|---|---|---|---|
| G.H. | 44 | 1 | 97 | 41 | 28 | 525 | ND |
| K.D.* | 12 | 1 | 97 | 24 | 74 | 363 | 0/20 |
| M.R.† | 52 | 4 | 99 | 3 | 6 | 2.5 | 0/20 |
| M.B.U. | 63 | 2 | 99 | 11 | 26 | 109 | 0/20 |
| M.B.A. | 64 | 3 | 92 | 13 | 8.3 | 26.5 | 0/50 |
| S.T. | 4 | 0 | 93 | 12 | 32 | 85 | 1/25 |
| L.C. | 1 | 0 | 94 | 16 | 20.2 | 19.5 | 0/20 |
| A.Z. | 5 | 0 | 90 | 6 | 20 | 19.5 | 0/20 |
| S.S. | 45 | 2 | 96 | 21 | 17.8 | 111 | 0/20 |
| P.S. | 51 | 1 | 97 | 8 | 5.4 | 24.2 | 0/20 |
| R.D.† | 40 | 4 | 99 | 4 | 2.5 | 2 | 0/20 |
| R.G. | 2 | 1 | 99 | 45 | 67 | 117 | 0/20 |
| G.T. | 34 | 4 | 99 | 3 | 11 | 7 | 0/20 |
| Median | 44 | 1 | 97 | 12 | 20.2 | 26.5 | |
| Range | 1-64 | 0-4 | 90-99 | 3-45 | 2.5-74 | 2-525 |
*Cultures initiated with bone marrow cells.
Cultures initiated with cryopreserved peripheral blood cells.